Hepatitis C: a challenge for the generalist

Most cases of hepatitis C become chronic, and although many of those remain silent for decades, some eventually progress to cirrhosis or other complications. Since almost 2% of the U.S. population is already infected, clinicians are likely to encounter growing numbers of patients with progressive disease. Treatment has been modified; ribavirin can now be added to interferon therapy.